Leiden University Medical Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
Leiden University Medical Center brings 4 presentations to ASH 2026 in New Orleans. Its program centres on cell therapy toxicity and clotting science. Sessions cover toxicities of T-cell redirecting therapy and the structural basis of clotting and clot breakdown.
| Organization | ASH 2026 Attendance |
|---|---|
Leiden University Medical Center Leiden, Netherlands | |
Academic medical centre of Leiden University in the Netherlands, combining patient care, research and medical education. | Session Sat Dec 12 8:00am–9:00am ASH Poster Walk on Emerging Toxicities and Predictors in T-Cell–Redirecting Therapies Hosted by Blood Immunology & Cellular Therapy Side effects of CAR-T and bispecific antibodies beyond the familiar ones, including long-lasting low blood counts and serious infections, and how to predict them. Talk Sat Dec 12 9:05am–9:30am Poster Sat Dec 12 5:30pm–7:30pm Poster Sat Dec 12 5:30pm–7:30pm Session Sun Dec 13 4:30pm–5:45pm Built to Clot, Built to Break: Structural Control of Hemostasis and Fibrinolysis Protein shape, force-sensitive interactions, and clot architecture govern how blood clots form and dissolve, pointing to new ways to treat bleeding. Session Mon Dec 14 4:30pm–6:00pm Special Symposium on the Basic Science of Hemostasis and Thrombosis (SSBSHT) New tools including multiomics, protein design, functional genomics, and AI applied to how blood clots form and dissolve, and to bleeding disorders. |
Find decision makers at Leiden University Medical Center
Tell us what you sell and we’ll find the people at Leiden University Medical Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction